Company / R&D per Share
ORAGENICS INC R&D per Share History
FY2013-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.34
FY2024
5-year range
$0.09 / $5.29
FY2020-FY2024
Trend
+1451.3%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share changed +1451% YoY in FY2024, a notable deviation from the 9-year average annual change of +689%.
Based on SEC 10-K filings.
1.34 in FY2024 with a 10-year CAGR of +31.7%.
Declined from $5.29 to $1.34 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +126.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- +31.7%
Key checks
Key Insights
- In FY2024, r&d per share increased 1451.3% year-over-year.
- Peak r&d per share was recorded in FY2022.
- Lowest r&d per share in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -147.03 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.34 | +1451.3% |
| FY2023 | $0.09 | -98.4% |
| FY2022 | $5.29 | +4481.6% |
| FY2021 | $0.12 | -90.5% |
| FY2018 | $1.21 | +25.2% |
| FY2017 | $0.97 | +341.7% |
| FY2016 | $0.22 | +158.6% |
| FY2015 | $0.08 | -0.5% |
| FY2014 | $0.09 | -70.3% |
| FY2013 | $0.29 | -78.5% |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026